Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2007

01-09-2007 | Original Paper

Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature

Authors: Alberto Luini, Giovanna Gatti, Jack Diaz, Edoardo Botteri, Eliegina Oliveira, Rafaela Cecilio Sahium de Almeida, Paolo Veronesi, Mattia Intra, Gianmatteo Pagani, Paola Naninato, Giuseppe Viale

Published in: Breast Cancer Research and Treatment | Issue 1/2007

Login to get access

Abstract

Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed.
Literature
1.
Cozen W, Bernstein L, Wang F et al (1999) The risk of angiosarcoma following primary breast cancer. Br J Cancer 81:532–536PubMedCrossRef
2.
Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1.041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679–1689PubMed
3.
Marchal C, Weber B, de Lafontan B et al (1999) Nine breast angiosarcomas after conservative treatment for breast carcinoma:a survey from French comprehensive cancer centers. Int J Radiat Oncol Biol Phys 44:113–119PubMedCrossRef
4.
Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92:172–180PubMedCrossRef
5.
Strobbe LJ, Peterse HL, van Tinteren H et al (1998) Angiosarcoma of breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela. Breast Cancer Res Treat 47:101–109PubMedCrossRef
6.
7.
Stokkel MP, Peterse HL (1992) Angiosarcoma of breast after lumpectomy and radiation therapy for adenocarcinoma. Cancer 69:2965–2968PubMedCrossRef
8.
Colville RJ, Ramsden A, Malcolm A, McLean NR (2000) Angiosarcoma of breast after quadrantectomy and postoperative radiotherapy for carcinoma. Br J Plast Surg 53:622–624PubMedCrossRef
9.
Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97:1832–1840PubMedCrossRef
10.
Cafiero F, Gipponi M, Peressini A et al (1996) Radiation-associated angiosarcoma:diagnostic and therapeutic implications – two case reports and review of the literature. Cancer 77:2496–2502PubMedCrossRef
11.
Brady MS, Gaynor JJ, Brennan MF (1992) Radiation-associated sarcoma of bone and soft tissue. Arch Surg 127:1379–1385PubMed
12.
Mark RJ, Poen J, Tran LM et al (1994) Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 73:2653–2662PubMedCrossRef
13.
Laskin WB, Silverman TA, Enzinger FM (1998) Postradiation soft tissue sarcomas:an analysis of 53 cases. Cancer 62:2330–2340CrossRef
14.
Pendlebury SC, Bilous M, Langlands AO (1995) Sarcomas following radiation therapy for breast cancer:a report of three cases and review of the literature. Int J Radiat Oncol Biol Phys 31:405–410PubMed
15.
Taghian A, de Vathaire F, Terrier P et al (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21:361–367PubMed
16.
17.
West JG, Qureshi A et al (2005) Risk of angiosarcoma following breast conservation:a clinical alert. Breast J 11:115–123PubMedCrossRef
18.
Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast- conserving therapy. Cancer 97:1832–1840PubMedCrossRef
19.
Blenda JA, Al-Jurf AS, Bensen AB 3rd. (1987) Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema. Am J Clin Pathol. 87:651–655
20.
Bolin DJ, Lukas GM (1996) Low-grade dermal angiosarcoma of the breast lollowing radiotherapy. Am Surg 62:668–672PubMed
21.
Woodward AH, Ivins JC, Soule EH (1972) Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 30:562–572PubMedCrossRef
22.
Billings SD, McKenney JK, Folper AL et al (2004) Cutaneus angiosarcoma following breast-conserving surgery and radiation:an analysis of 27 cases. Am J Surg Pathol 28:781–788PubMedCrossRef
23.
Fant J, Grant May S, Talaasen L, Watkins D (2003) Angiosarcoma of the breast:mammographic, clinical and pathologic correlation. Breast J 9:252–253PubMedCrossRef
24.
Liberman L, Dershaw DD, Kaufman RJ, Rosen PP (1992) Angiosarcoma of the breast. Radiology 183:649–654PubMed
25.
Rosen PP Sarcoma (2001) In: Rosen PP (ed) Rosen’s Breast pathology. Williams & Wilkins, Philadelphia Lippincott, pp 813–861
26.
Naka N, Ohsawa M, Tomita Y et al (1996) Prognostic factors in angiosarcoma:a multivariate analysis of 55 cases. J Surg Oncol 61:170–176PubMedCrossRef
27.
Feigenberg SJ, Mendenhall NP, Reith JD, Ward JR, Copeland EM 3rd. (2002) Angiosarcoma after breast-conserving therapy:experience with hyperfractionated radiotherapy. Int J Radiat Biol Phys 52:620–626CrossRef
Metadata
Title
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature
Authors
Alberto Luini
Giovanna Gatti
Jack Diaz
Edoardo Botteri
Eliegina Oliveira
Rafaela Cecilio Sahium de Almeida
Paolo Veronesi
Mattia Intra
Gianmatteo Pagani
Paola Naninato
Giuseppe Viale
Publication date
01-09-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9429-z

Other articles of this Issue 1/2007

Breast Cancer Research and Treatment 1/2007 Go to the issue

Clinical Epidemiology

Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study

EPIDEMILOGY

Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

Pre-clinical Study

Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications

Epidemiology

Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis

Critical Trial

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer

Clinical Study

Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits